KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to 31.68%.

  • Opko Health's EBITDA Margin fell 273000.0% to 31.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.48%, marking a year-over-year increase of 159700.0%. This contributed to the annual value of 21.32% for FY2024, which is 31400.0% down from last year.
  • Latest data reveals that Opko Health reported EBITDA Margin of 31.68% as of Q3 2025, which was down 273000.0% from 38.25% recorded in Q2 2025.
  • Opko Health's 5-year EBITDA Margin high stood at 3782.6% for Q3 2021, and its period low was 1223.76% during Q1 2023.
  • Its 5-year average for EBITDA Margin is 120.55%, with a median of 22.0% in 2022.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 37774700bps in 2021, then crashed by -38314600bps in 2022.
  • Over the past 5 years, Opko Health's EBITDA Margin (Quarter) stood at 15.72% in 2021, then tumbled by -90bps to 29.82% in 2022, then decreased by -27bps to 37.96% in 2023, then surged by 52bps to 18.05% in 2024, then skyrocketed by 276bps to 31.68% in 2025.
  • Its EBITDA Margin stands at 31.68% for Q3 2025, versus 38.25% for Q2 2025 and 44.79% for Q1 2025.